review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1040290574 |
P356 | DOI | 10.1186/CC1467 |
P932 | PMC publication ID | 137290 |
P698 | PubMed publication ID | 11983034 |
P5875 | ResearchGate publication ID | 11386674 |
P2093 | author name string | Keith R Walley | |
Randy Wax | |||
Carmine Simone | |||
Frank V Ritacca | |||
Katherine G Craig | |||
P2860 | cites work | Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 |
Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study | Q33861751 | ||
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin | Q33891791 | ||
Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations | Q33893291 | ||
Steroid controversy in sepsis and septic shock: a meta-analysis | Q34299045 | ||
Reversal of late septic shock with supraphysiologic doses of hydrocortisone | Q34465500 | ||
Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections | Q40082523 | ||
Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. | Q40460082 | ||
Beta-adrenergic receptors and their regulation | Q40476279 | ||
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
Corticosteroid therapy in severe illness | Q41621793 | ||
The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone | Q43541017 | ||
Corticosteroids in septic shock: resurrection of the last rites? | Q43668242 | ||
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group | Q46886444 | ||
The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. | Q51978484 | ||
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. | Q53753081 | ||
Variable adrenocortical function in acute medical illness | Q70085436 | ||
Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality | Q70186741 | ||
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group | Q72472826 | ||
Beta-blocker therapy for heart failure: the evidence is in, now the work begins | Q73543021 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | intensive care medicine | Q679690 |
septic shock | Q1765564 | ||
adrenal cortex hormone | Q38638276 | ||
attitude of health personnel | Q60589811 | ||
P304 | page(s) | 113-116 | |
P577 | publication date | 2002-02-06 | |
2002-04-01 | |||
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Pro/con clinical debate: are steroids useful in the management of patients with septic shock? | |
P478 | volume | 6 |
Search more.